Patent · US Expired

Selective protein tyrosine phosphatatase inhibitors

US6972340B2 · kind B2 · utility

1Cited by
3References
72Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 29, 2001
Grant dateDec 6, 2005
Priority date
Expiry dateJun 14, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2602/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of formula (I) or therapeutically acceptable salts thereof, are selective protein tyrosine kinase-B (PTP1B) inhibitors. Preparation of the compounds, compositions containing the compounds, and treatment of disorders using the compounds are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.